ACMSD anticorps (Middle Region)

N° du produit ABIN1105224

Détail du produit anti-ACMSD anticorps

Antigène: ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))

Épitope: Middle Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ACMSD est non-conjugé

Application: Western Blotting (WB)

Séquence: NPMNPKKYLG SFYTDALVHD PLSLKLLTDV IGKDKVILGT DYPFPLGELE

Réactivité croisée (Details): Species reactivity (expected):Bovine, Mouse, Rat, Dog, Pig, Rabbit, ZebrafishSpecies reactivity (tested):Human

Purification: Purified using peptide immunoaffinity column

Immunogène: Synthetic peptide directed towards the middle region of human ACMSD

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Reconstitution: Add 50 μL of distilled water to a final concentration of 1 mg/mL.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.

Détails sur ACMSD

Antigène: ACMSD (Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD))

Autre désignation: ACMSD (ACMSD Produits)

Synonymes: anticorps zgc:162888, anticorps ACMSD, anticorps aminocarboxymuconate semialdehyde decarboxylase, anticorps aminocarboxymuconate semialdehyde decarboxylase S homeolog, anticorps amino carboxymuconate semialdehyde decarboxylase, anticorps ACMSD, anticorps acmsd, anticorps acmsd.S, anticorps Acmsd

Sujet: 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase converts alpha-amino-beta-carboxymuconate-epsilon-semialdehyde (ACMS) to alpha-aminomuconate semialdehyde (AMS). ACMS can be converted non-enzymatically to quinolate (QA), a key precursor of NAD, and a potent endogenous excitotoxin of neuronal cells which is implicated in the pathogenesis of various neurodegenerative disorders. In the presence of ACMSD, ACMS is converted to AMS, a benign catabolite. ACMSD ultimately controls the metabolic fate of tryptophan catabolism along the kynurenine pathway.2-amino-3-carboxymuconate-6-semialdehyde decarboxylaseSynonyms: 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase

ID gène: 130013

NCBI Accession: NP_612199